Old Web
English
Sign In
Acemap
>
authorDetail
>
Gianluigi Cetto
Gianluigi Cetto
University of Verona
Medicine
Pathology
Chemotherapy
Small-cell carcinoma
Etoposide
3
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Rituximab Reduces Anti-UL94 and Anti-NAG-2 Antibodies Titer and Is Effective against Skin-Chronic Graft Versus Host Disease Resembling Scleroderma.
2009
Blood
Rocco Pastano
Chiara Dell’Agnola
Caterina Bason
Federica Gigli
Cristina Rabascio
Antonio Puccetti
Gianluigi Cetto
Fedro Alessandro Peccatori
Giovanni Martinelli
Claudio Lunardi
Show All
Source
Cite
Save
Citations (0)
A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV‐E) or teniposide (CAV‐T), followed by recombinant interferon‐α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses
1997
Cancer
Diego Tummarello
Davide Mari
Francesco Graziano
Pierpaolo Isidori
Gianluigi Cetto
Felice Pasini
Antonio Santo
Riccardo Cellerino
Show All
Source
Cite
Save
Citations (32)
Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
1996
Cancer
Diego Tummarello
Francesco Graziano
Pierpaolo Isidori
Antonio Santo
Gianluigi Cetto
Anna Fedeli
Giorgio Rossi
Riccardo Cellerino
Show All
Source
Cite
Save
Citations (10)
1